Showing posts with label vitamin D3. Show all posts
Showing posts with label vitamin D3. Show all posts

Wednesday, March 17, 2010

Mighty Vitamin D Better Than Vaccines at Preventing Flu in Children

Note in the news article below that the protective benefits of Vitamin D against the flu did not kick in until blood levels of the vitamin were high enough.


This means you have to be taking Vitamin D regularly, in order to enjoy the protective effects.


It is astonishing, of course, than an inexpensive vitamin can cut flu cases IN HALF in children, whereas expensive prescription vaccines costing taxpayers billions of dollars annually cut the risk of flu infection by only a meager 8%.


Once again, natural trumps unnatural.


‘Nuff said.


-- Spencer



Report: Vitamin D Better Than Vaccines at Preventing Flu in Children


By Oliver Gillie, TimesOnline.co.uk


Vitamin D could cut the risk of flu infection in children by half, the report claims


The risk of children suffering from flu can be halved if they take vitamin D, doctors in Japan have found. The finding has implications for flu epidemics since vitamin D, which is naturally produced by the human body when exposed to direct sunlight, has no significant side effects, costs little and can be several times more effective than anti-viral drugs or vaccine.


Only one in ten children, aged six to 15 years, taking the sunshine vitamin in a clinical trial came down with flu compared with one in five given a dummy tablet. Mitsuyoshi Urashima, the Japanese doctor who led the trial, told The Times that vitamin D was more effective than vaccines in preventing flu.


Vitamin D was found to be even more effective when the comparison left out children who were already given extra vitamin D by their parents, outside the trial. Taking the sunshine vitamin was then shown to reduce the risk of flu to a third of what it would otherwise be.


Altogether 354 children took part in the trial, which took place during the winter of 2008-09, before the swine flu epidemic. Vitamin D was found to protect against influenza A, which caused last year’s epidemic, but not against the less common influenza B.


The trial, which was double blind, randomised, and fully controlled scientifically, was conducted by doctors and scientists from Jikei University School of Medicine in Tokyo, Japan.


The children were given a daily dose of 1200 IUs (international units) of vitamin D over a period of three months. In the first month children in the group taking the vitamin became ill just as often as those taking the dummy tablet. But by the second month, when the vitamin level in the children’s blood was higher, the advantage of the vitamin was clear.


The Japanese scientists, writing in the American Journal of Clinical Nutrition, say that the anti-viral drugs zanamivir and oseltamivir reduce risk of flu infection by 8 per cent in children who have been exposed to infection, compared with a 50 per cent or greater reduction with vitamin D.


Anti-virals are also too expensive, and possibly too toxic, to be given to the population as a whole whereas vitamin D has additional benefits. The sunshine vitamin not only prevents bone fractures but is also believed to reduce risks of cancer, heart disease, diabetes and other illness, including various bacterial as well as viral infections.


The Japanese finding supports a theory that low blood levels of the sunshine vitamin occurring in winter explain why flu epidemics generally peak between December and March.


Vitamin D activates the innate immune system, enabling the body to produce several proteins such as defensin and cathelicidin which trigger cell activity and disable viruses.


Dr Urashima said: “Vitamin D and vaccine work by quite different mechanisms. Vitamin D enhances innate immunity while vaccine enhances acquired immunity. So we do not have to select only one way of prevention, rather we should do both ways, I think.”


Dr John Oxford, professor of virology at Queen Mary School of Medicine, London, said: “This is a timely study. It will be noticed by scientists. It fits in with the seasonal pattern of flu. There is an increasing background of solid science that makes the vitamin D story credible. But this study needs to be replicated. If it is confirmed we might think of giving vitamin D at the same time as we vaccinate.”


Helpful Links:

www.DRiboseAdvantage.com

www.VinpocetineGold.com

www.MacaRootAdvantage.com

www.DMGAdvantage.com

www.PregnenoloneAdvantage.com

www.CMOSupreme.com

www.HoodiaMaximus.com

www.Jubilee3JointRelief.com

http://www.thesilveredge.com/

Colloidal Silver Secrets Group on Facebook

The Authoritative Guide to Vaccine Legal Exemptions

Friday, November 20, 2009

Death by Tamiflu-Resistant Swine Flu, or Death by Tamiflu?

I find several things interesting and disconcerting about the below news article.

First, the cluster of Tamiflu-resistant swine flu is all in the same state.

Second, the latest four victims were all patients in the same hospital.

Third, they were all hospitalized for reasons other than the flu, which is to say, they caught the flu in the hospital.

And fourth, they were all given Tamiflu, and three out of four of them died.

Considering reports coming in from other countries of Tamiflu's toxicity, which in a number of cases has led to patient deaths (see here, and here), couldn't it have been the Tamiflu that killed these latest victims?

Might not the growing news reports of "Tamiflu-resistant swine flu" be exaggerated cover-ups for the simple fact that Tamiflu is still killing people, particularly when it is adminstered to people who are already sick with other illnesses?

I don't know about you, but I think I'll do my darndest to stay out of hospitals, and stick with my high-dose Vitamin C, a good probiotic supplement, plenty of Vitamin D3, and of course my favorite all-natural antiviral supplement, colloidal silver. See http://www.colloidalsilverkillsviruses.com/

-- Spencer

Tamiflu-resistant swine flu cluster reported in NC

http://news.yahoo.com/s/ap/20091120/ap_on_he_me/us_med_swine_flu

By MIKE STOBBE, AP Medical Writer Mike Stobbe, Ap Medical Writer

ATLANTA – Four North Carolina patients at a single hospital tested positive for a type of swine flu that is resistant to Tamiflu, health officials said Friday.

The cases reported at Duke University Medical Center over six weeks make up the biggest cluster seen so far in the U.S.

Tamiflu — made by Switzerland's Roche Group — is one of two flu medicines that help against swine flu, and health officials have been closely watching for signs that the virus is mutating, making the drugs ineffective.

More than 50 resistant cases have been reported in the world since April, including 21 in the U.S. Almost all in the U.S. were isolated, said officials with the U.S. Centers for Disease Control and Prevention.

The BBC reported another cluster of five Tamiflu-resistant cases this week in Wales, in the United Kingdom.

The CDC has sent three disease investigators to North Carolina to help in the investigation there, said Dave Daigle, a CDC spokesman. CDC testing confirmed the Tamiflu-resistant cases.

All four cases at the hospital were very ill patients in an isolated cancer unit on the hospital's ninth floor, and it is believed they all caught the flu while at the hospital, said Dr. Daniel Sexton, professor of medicine and director of the Duke Infection Control Outreach Network.

Three of the four patients died and one is recovering, he said. Flu seems to have been a factor in each death, but they were very sick so it was hard to say that it was the primary cause, he added.

North Carolina health officials did not disclose details about the four patients, other than that three of them — including the survivor — were women and their flu illnesses occurred last month and this month.

The first patient had been given Tamiflu before becoming ill with the virus, as a preventive measure. The three others were given Tamiflu after developing flu symptoms, Sexton said.

The case is under investigation, but hospital officials said they have no evidence the cases represent a hospital-wide concern.

The North Carolina cluster is unusual, but "at this time we don't have any information that should raise concerns for the general population," said Dr. Alicia Frye, epidemiologist in the CDC's flu division, in a prepared statement.

The only other reported U.S. instance of Tamiflu-resistant swine flu spreading from one person to another occurred about four months ago at a summer camp in western North Carolina, where two teenage girls — cabin mates — were diagnosed with the same drug-resistant strain. Health officials said at the time that the virus may have spread from one girl to the other, or it's possible that the girls got it from another camper.

Why did both Tamiflu-resistant clusters occur in North Carolina? It could be coincidence, or perhaps North Carolina's disease surveillance is unusually good, said Megan Davies, the state's epidemiologist.

Overall, CDC officials said Friday that swine flu cases appear to be declining throughout most of the U.S., with reports of swine flu illnesses widespread in 43 states last week, down from 46 the week before.

CDC officials also said reports have been increasing in a few states, including Maine and Hawaii. They said it's hard to know whether the epidemic has peaked or not.

Thanksgiving and the holidays may not help matters, said Dr. Anne Schuchat, who heads the CDC's National Center for Immunization and Respiratory Diseases.

"All the kids get together with their grandparents and there's a lot of exchange of warmth and love, but a little exchange of viruses, too," she said.

Swine flu has sickened an estimated 22 million Americans, hospitalized about 98,000 and killed 4,000 since it was first identified last April. It has proved to be similar to seasonal flu but a much bigger threat to children and young adults.

Helpful Links:

The Immune Manual

Colloidal Silver Kills Viruses

Colloidal Silver Cures MRSA

Colloidal Silver Secrets blog

Make Your Own Colloidal Silver

The Colloidal Silver Secrets Video

The Ultimate Colloidal Silver Manual

The New Micro-Particle Colloidal Silver Generator

The Authoritative Guide to Vaccine Legal Exemptions